TrialCompass TCL
Back to results
NARecruitingPriority 4 · Lower priorityNCT05333367

MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy

ClinicalTrials.gov

Plain-language summary

This NA trial is studying Samples collection for people with cutaneous T-cell lymphoma (skin lymphoma). The study measures how well this treatment works and monitors for side effects. This trial does not currently list US sites.

Who can join (key eligibility)

  • Age 18 Years to 85 Years years
  • See full trial listing for complete eligibility

Final eligibility is determined by the trial team. This list is a starting point only.

What's being tested

Samples collection (OTHER): Sampling of 2 samples on the extracorporeal photochemotherapy circuit, before and after sensitization with 8-MOP and UVA irradiation (without additional puncture)

Drugs / treatments
Samples collection
Treatment length
Ask the trial team for details
Visit frequency
Ask the trial team for details
TrialCompass — Clinical Trial Summary

MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy

NCT05333367

Phase: NA | Status: Recruiting | Priority: Lower

Plain-language summary

This NA trial is studying Samples collection for people with cutaneous T-cell lymphoma (skin lymphoma). The study measures how well this treatment works and monitors for side effects. This trial does not currently list US sites.

Who can join

  • Age 18 Years to 85 Years years
  • See full trial listing for complete eligibility

What's being tested

Samples collection (OTHER): Sampling of 2 samples on the extracorporeal photochemotherapy circuit, before and after sensitization with 8-MOP and UVA irradiation (without additional puncture)

Drugs / treatments: Samples collection

Treatment length: Ask the trial team for details

Visit frequency: Ask the trial team for details

Trial design

Non-randomized, open-label

Enrollment target: 20 patients

Primary endpoint: Type of cell death induced by 8-MOP sensitization and UVA irradiation; Type of cell death induced by 8-MOP sensitization and UVA irradiation; Type of cell death induced by 8-MOP sensitization and UVA irradiation

Ages: 18 Years to 85 Years

Start date: 2022-04-15 | Est. completion: 2025-07

Locations

0 US sites · 1 total

Contact

Charline VAUCHY, PhD | cvauchy@chu-besancon.fr | +33381218875

Sponsor: Centre Hospitalier Universitaire de Besancon (OTHER)

Tags

CTCL · any

View on ClinicalTrials.gov

https://clinicaltrials.gov/study/NCT05333367

Prepared using TrialCompass (trialcompass.com) on June 19, 2026. For informational purposes only. Always discuss with your healthcare team.